p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3

Wales, Michele Makos, Biel, Margaret A., Deiry, Wafik El, Nelkin, Barry D., Issa, Jean-Pierre, Cavenee, Webster K., Kuerbitz, Steven J., Baylin, Stephen B.·1995·Nature Medicine
DOI 10.1038/nm0695-570

Cited by (420)

Items 401–420 of 420

  1. Genetic aberrations and their clinical significance in breast and ovarian cancer
    Virpi Launonen · 1999
  2. p53 and Its Targets
    Rishu Takimoto, Wafik S. El‐Deiry · 2002 · Elsevier eBooks
  3. Deletions of the YNZ22and Alu-VpA/MycL1Loci and Post-Surgery Prognosis in Human Colorectal Adenocarcinoma
    К. Н. Кашкин, Andrey Vladimirovich Nikolaev, Dmitry A. Turbin, A. G. Perevoschikov · 2001 · Molecular Biology
  4. The role of PATZ1 transcription factor in the DNA damage response
    Emre Deniz · 2014 · Sabanci University
  5. Epigenetic regulation of tumor angiogenesis
    Debby M.E.I. Hellebrekers · 2006
  6. References
    2013 · Elsevier eBooks
  7. Chromosome 17
    Sarah J. Plummer, Graham Casey · 2002 · Wiley Encyclopedia of Molecular Medicine
  8. True
    Gavin Nicoll, H E McDowell, Alastair Mark Thompson, D.N. Crichton, Neil Kernohan, T R Hupp · 2001 · British Journal of Cancer
  9. Tumor suppressor Hypermethylated in Cancer 1 represses expression of cell cycle regulator E2F7 in human primary cells
    Lucie Lanikova, Jiří Švec, Lucie Janečková, Vendula Pospíchalová, Nikol Dibus, Martina Vojtěchová, Dušan Hrčkulák, Eva Šloncová, Hynek Strnad, Vladimír Kořínek · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  10. Data from Identification and Functional Characterization of a Novel Unspliced Transcript Variant of HIC-1 in Human Cancer Cells Exposed to Adverse Growth Conditions
    Abdul Matin Mondal, Sivasamy Chinnadurai, Kamal Datta, Shyam Singh Chauhan, Subrata Sinha, Parthaprasad Chattopadhyay · 2023
  11. Data from Identification and Functional Characterization of a Novel Unspliced Transcript Variant of HIC-1 in Human Cancer Cells Exposed to Adverse Growth Conditions
    Abdul Matin Mondal, Sivasamy Chinnadurai, Kamal Datta, Shyam Singh Chauhan, Subrata Sinha, Parthaprasad Chattopadhyay · 2023
  12. Data from Mnt-Deficient Mammary Glands Exhibit Impaired Involution and Tumors with Characteristics of Myc Overexpression
    Kazuhito Toyo‐oka, Timothy J. Bowen, Shinji Hirotsune, Zirong Li, Sonia Jain, Sara Ota, Laure Escoubet‐Lozach, Ivan García-Bassets, Jean Lozach, Michael G. Rosenfeld et al. · 2023
  13. Data from Methylation of Serum DNA Is an Independent Prognostic Marker in Colorectal Cancer
    Maike Wallner, Andreas Herbst, Andrea Behrens, Alexander Crispin, P Stieber, Burkhard Göke, R. Lamerz, Frank Thomas Kolligs · 2023
  14. Basic and Translational Science in Oncology
    Dimple R. Bhatia, Sudeep Gupta · 2024 · Springer eBooks
  15. Chromosome 17p loss and coagulation dysregulation in breast cancer: implications for metastatic risk – a narrative review
    Emmanuel Ifeanyi Obeagu · 2026 · Annals of Medicine and Surgery
  16. Fonctions métaboliques de Sirtuine 1 dans le muscle strié squelettique : contribution à l'étude de la régulation de l'expression de SREBP-1c et rôle potentiel lors d'un jeûne chez des myotubes C2C12
    Aurélia Defour · 2010
  17. Contre-mesures virales anti-CTIP2 dans le cadre d'une infection productive par le ViH-1
    Faezeh Forouzanfar · 2016 · theses.fr (ABES)
  18. La delta-lactoferrine : un facteur de transcription régulé par SUMOylation
    Adelma Escobar-Ramírez · 2014
  19. Le suppresseur de tumeur HIC1 est une nouvelle cible directe de la kinase ATM et un acteur multifonctionnel de la réponse cellulaire aux cassures double brin (DSBs) de l’ADN
    Sonia Paget · 2016 · theses.fr (ABES)
  20. The interplay between genetics and epigenetics in colorectal cancer
    Sarah Derks · 2009